These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30413627)

  • 1. Exploring the Potential of RET Kinase Inhibition for Irritable Bowel Syndrome: A Preclinical Investigation in Rodent Models of Colonic Hypersensitivity.
    Russell JP; Mohammadi E; Ligon CO; Johnson AC; Gershon MD; Rao M; Shen Y; Chan CC; Eidam HS; DeMartino MP; Cheung M; Oliff AI; Kumar S; Greenwood-Van Meerveld B
    J Pharmacol Exp Ther; 2019 Feb; 368(2):299-307. PubMed ID: 30413627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Monoclonal Anti-Calcitonin Gene-Related Peptide Antibody Decreases Stress-Induced Colonic Hypersensitivity.
    Noor-Mohammadi E; Ligon CO; Mackenzie K; Stratton J; Shnider S; Greenwood-Van Meerveld B
    J Pharmacol Exp Ther; 2021 Nov; 379(3):270-279. PubMed ID: 34620725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteric RET inhibition attenuates gastrointestinal secretion and motility via cholinergic signaling in rat colonic mucosal preparations.
    Russell JP; Mohammadi E; Ligon C; Latorre R; Johnson AC; Hoang B; Krull D; Ho MW; Eidam HS; DeMartino MP; Cheung M; Oliff AI; Kumar S; Greenwood-Van Meerveld B
    Neurogastroenterol Motil; 2019 Apr; 31(4):e13479. PubMed ID: 30311722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute stress disrupts intestinal homeostasis via GDNF-RET.
    Lin L; Feng B; Zhou R; Liu Y; Li L; Wang K; Yu Y; Liu C; Long X; Gu X; Li B; Wang X; Yang X; Cong Y; Zuo X; Li Y
    Cell Prolif; 2020 Oct; 53(10):e12889. PubMed ID: 32808420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a First-in-Class Gut-Restricted RET Kinase Inhibitor as a Clinical Candidate for the Treatment of IBS.
    Schenck Eidam H; Russell J; Raha K; DeMartino M; Qin D; Guan HA; Zhang Z; Zhen G; Yu H; Wu C; Pan Y; Joberty G; Zinn N; Laquerre S; Robinson S; White A; Giddings A; Mohammadi E; Greenwood-Van Meerveld B; Oliff A; Kumar S; Cheung M
    ACS Med Chem Lett; 2018 Jul; 9(7):623-628. PubMed ID: 30034590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitin-glucan improves important pathophysiological features of irritable bowel syndrome.
    Valibouze C; Dubuquoy C; Chavatte P; Genin M; Maquet V; Modica S; Desreumaux P; Rousseaux C
    World J Gastroenterol; 2024 Apr; 30(16):2258-2271. PubMed ID: 38690023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phlorizin attenuates visceral hypersensitivity and colonic hyperpermeability in a rat model of irritable bowel syndrome.
    Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Biomed Pharmacother; 2021 Jul; 139():111649. PubMed ID: 33957565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome.
    Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Eur J Pharmacol; 2020 Nov; 887():173565. PubMed ID: 32946869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats.
    Botschuijver S; Roeselers G; Levin E; Jonkers DM; Welting O; Heinsbroek SEM; de Weerd HH; Boekhout T; Fornai M; Masclee AA; Schuren FHJ; de Jonge WJ; Seppen J; van den Wijngaard RM
    Gastroenterology; 2017 Oct; 153(4):1026-1039. PubMed ID: 28624575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive Effects of an Anti-CGRP Antibody in Rat Models of Colon-Bladder Cross-Organ Sensitization.
    Noor-Mohammadi E; Ligon CO; Mackenzie KD; Stratton J; Shnider SJ; Greenwood-Van Meerveld B
    J Pharmacol Exp Ther; 2023 Oct; 387(1):4-14. PubMed ID: 37164371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats.
    Yu ZC; Cen YX; Wu BH; Wei C; Xiong F; Li DF; Liu TT; Luo MH; Guo LL; Li YX; Wang LS; Wang JY; Yao J
    World J Gastroenterol; 2019 Aug; 25(29):3956-3971. PubMed ID: 31413530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of neonatal maternal separation on neurochemical and sensory response to colonic distension in a rat model of irritable bowel syndrome.
    Ren TH; Wu J; Yew D; Ziea E; Lao L; Leung WK; Berman B; Hu PJ; Sung JJ
    Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G849-56. PubMed ID: 17110521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dehydroepiandrosterone sulfate improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    Eur J Pharmacol; 2019 Jun; 852():198-206. PubMed ID: 30935894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR4 upregulates CBS expression through NF-κB activation in a rat model of irritable bowel syndrome with chronic visceral hypersensitivity.
    Yuan B; Tang WH; Lu LJ; Zhou Y; Zhu HY; Zhou YL; Zhang HH; Hu CY; Xu GY
    World J Gastroenterol; 2015 Jul; 21(28):8615-28. PubMed ID: 26229403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats.
    Nozu T; Miyagishi S; Kumei S; Nozu R; Takakusaki K; Okumura T
    J Gastroenterol Hepatol; 2019 Jan; 34(1):186-193. PubMed ID: 29966173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate.
    Castro J; Harrington AM; Hughes PA; Martin CM; Ge P; Shea CM; Jin H; Jacobson S; Hannig G; Mann E; Cohen MB; MacDougall JE; Lavins BJ; Kurtz CB; Silos-Santiago I; Johnston JM; Currie MG; Blackshaw LA; Brierley SM
    Gastroenterology; 2013 Dec; 145(6):1334-46.e1-11. PubMed ID: 23958540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2Y1R is involved in visceral hypersensitivity in rats with experimental irritable bowel syndrome.
    Wu J; Cheng Y; Zhang R; Liu D; Luo YM; Chen KL; Ren S; Zhang J
    World J Gastroenterol; 2017 Sep; 23(34):6339-6349. PubMed ID: 28974901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive Effect of Ghrelin in a Rat Model of Irritable Bowel Syndrome Involves TRPV1/Opioid Systems.
    Mao Y; Li Z; Chen K; Yu H; Zhang S; Jiang M; Ma Y; Liang C; Liu H; Li H; Hua Q; Zhou H; Sun Y; Fan X
    Cell Physiol Biochem; 2017; 43(2):518-530. PubMed ID: 28930716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of SKI3246, the rhizome extract of Atractylodes japonica, on visceral hypersensitivity in experimental irritable bowel syndrome rat models.
    Son HJ; Jung K; Park YH; Jeon HJ; Kang M; Ryu KH; Pyo SS; Eutamene H; Bueno L; Sun WS
    Arch Pharm Res; 2015; 38(5):642-9. PubMed ID: 25070763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    Sci Rep; 2019 Dec; 9(1):19603. PubMed ID: 31862976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.